+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF and plasma GABA levels in Parkinson's disease

CSF and plasma GABA levels in Parkinson's disease

Journal of Neurology, Neurosurgery, and Psychiatry 45(3): 253-256

CSF gamma-aminobutyric acid (GABA) levels were reduced in patients with idiopathic Parkinson's disease when compared with age matched controls, but the difference was not significant. However, when the Parkinsonian patients were subdivided, CSF GABA levels were lower in the levodopa treated group than in the untreated group and the controls. There was no difference in plasma GABA levels between Parkinsonian patients and controls.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 042429233

Download citation: RISBibTeXText

PMID: 7086446

DOI: 10.1136/jnnp.45.3.253

Related references

CSF GABA levels in Parkinson's disease. Advances in Neurology 40: 427-430, 1984

Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. Plos One 7(1): E30918-E30918, 2012

Plasma levels of vitamin E in Parkinson's disease. Archives of Gerontology & Geriatrics 33(1): 7-12, July/August, 2001

Plasma levels of vitamin E in Parkinson's disease. Journal of Neural Transmission. Supplementum 45: 267-270, 1995

Plasma homocysteine levels and Parkinson disease: disease progression, carotid intima-media thickness and neuropsychiatric complications. Clinical Neuropharmacology 29(6): 305-311, 2006

Plasma levels of nitrates in patients with Parkinson's disease. Journal of the Neurological Sciences 127(1): 87-89, 1994

Elevated plasma levels of homocysteine in Parkinson's disease. European Neurology 40(4): 225-227, 1998

Plasma F2A lsoprostane levels in Alzheimer's and Parkinson's disease. Neurodegenerative Diseases 4(6): 403-405, 2007

Plasma beta-lipotropin levels in Parkinson's disease. Journal of Neural Transmission 53(1): 75-82, 1982

Effect of isoniazid on cerebrospinal fluid and plasma GABA levels in Huntington's disease. Life Sciences 26(16): 1303-1308, 1980

Sulfate and cysteine levels in the plasma of patients with Parkinson's disease. Neurotoxicology 16(3): 527-529, 1995

Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease. Neuroscience Letters 425(1): 18-22, 2007

Increases of pentraxin 3 plasma levels in patients with Parkinson's disease. Movement Disorders 26(13): 2364-2370, 2012